Kevin Panico - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kevin Panico

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

The American Journal of Hospice & Palliative Care|April 2, 2004

Institutional patterns of symptomatic medication in hospitalized patients with advanced cancerKevin Panico, Paolo Manfredi

Journal of Pain and Symptom Management|February 19, 2003

Myocardial infarction associated with diffuse painKevin Panico, Paolo L Manfredi

Cancer Chemotherapy and Pharmacology|May 11, 2006

Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patientsMiguel Villalona-Calero, Larry Schaaf, Gary Phillips, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

The American Journal of Hospice & Palliative Care|April 2, 2004

Institutional patterns of symptomatic medication in hospitalized patients with advanced cancerKevin Panico, Paolo Manfredi

Journal of Pain and Symptom Management|February 19, 2003

Myocardial infarction associated with diffuse painKevin Panico, Paolo L Manfredi

Cancer Chemotherapy and Pharmacology|May 11, 2006

Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patientsMiguel Villalona-Calero, Larry Schaaf, Gary Phillips, et al.

Pageof 1